Illumina Inc. (ILMN) Stock Research, Analysis & News

Quick Analysis on Illumina Inc. (ILMN) Stock as of January 28, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Illumina Inc. (ILMN) Stock below)

Illumina Inc. (ILMN) Stock Profile Summary

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The companys consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are customer designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services. The companys customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as research centers. It sells its products through distributors in North America, Europe, the Asia-Pacific, the Middle East, and South Africa. Illumina was founded in 1998 and is headquartered in San Diego, California.

Illumina Inc. (ILMN) Stock Key Statistics Research and Analysis as of January 28, 2020

Illumina Inc. (ILMN) Stock Competitor Research and Analysis

Affymetrix Inc. (AFFX)Life Technologies Corporation (LIFE)
Luminex Corporation (LMNX)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)

Mutual Funds with Illumina Inc. (ILMN) Stock in its top 10 holdings

FundCategoryILMN Holding Percentage
Baron Asset RetailMid-Cap Growth3.25%
Baron Opportunity InstlMid-Cap Growth3.44%
ProFunds Biotechnology UltraSector InvTrading--Leveraged Equity2.37%
Baron Partners InstlMid-Cap Growth4.78%
Bishop Street Strategic Growth InstlLarge Growth4.15%
Morgan Stanley Multi Cap Growth ALarge Growth4.44%

ETFs with Illumina Inc. (ILMN) Stock in its top 10 holdings

Stock Research on Illumina Inc. (ILMN)

Latest Market News on Illumina Inc. (ILMN)

Click here to find the latest news on Illumina Inc. (ILMN)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Affymetrix Inc. (AFFX)
Life Technologies Corporation (LIFE)
Luminex Corporation (LMNX)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)